Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Top FDA official takes over vaccine office as agency weighs COVID-19 shots for children
Peter Marks, one of the Food and Drug Administration's top-ranking officials, has taken over the agency's vaccine review office just as the regulator begins considering whether to clear corona...
AstraZeneca to buy rare disease drugmaker Caelum in small dealer
AstraZeneca on Wednesday said it will exercise an option to buy the rest of rare disease drugmaker Caelum Biosciences for $150 million, betting on the promise of an experimental medicine to treat ligh...
NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer
EDINBURGH, United Kingdom, Sept.
Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway
TOKYO and CAMBRIDGE, Mass, September 27, 2021 - Eisai Co.
France's Sanofi halts work on anti-Covid vaccine
France's pharmaceutical giant Sanofi, which has lagged rivals in producing new generation Covid-19 vaccines, has said it has decided to halt development of an mRNA candidate and focus on another v...
FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies
September marks Alzheimer’s Awareness Month and Dr.
Kids too young for a COVID-19 vaccine? How to keep them safe
With the arrival of the fourth wave of COVID-19 in Canada, and vaccines not yet approved for children under 12, what measures can parents take to protect kids who are not yet immunized?Dr.
More effective treatment of Alzheimer's
Developing effective treatment methods for Alzheimer's disease has proved difficult.
A new oral antiviral drug for COVID is being tested in humans
Despite the effectiveness of vaccines, we still need drugs to treat COVID.
GeneTx and Ultragenyx Announce FDA has Removed Clinical Hold on Phase 1/2 Clinical Study of GTX-102 for the Treatment of Angelman Syndrome in the U.S.
SARASOTA, Fla.
ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular Dystrophy
Rockville, MD, USA, and Pratteln, Switzerland, September 27, 2021 – ReveraGen Biopharma and Santhera Pharmaceuticals (SIX.
Japan panel approves second drug for mildly ill COVID-19 patients
A health ministry expert committee on Monday approved a single-dose monoclonal antibody-based treatment developed by British drugmaker GlaxoSmithKline PLC and U.
196
197
198
199
200
201
202
203
204
